FEDERALhearing transcript

Congressional Hearing on COVID-19 Variants and Research Needs

Original title: COVID-19 VARIANTS AND EVOLVING RESEARCH NEEDS

January 1, 2022

COVID-19 public health vaccines epidemiology scientific research viral variants

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing established the federal legislative record on the scientific challenges posed by COVID-19 mutations, which informs future public health funding and national pandemic response strategies.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

General Public

The research discussed impacts national public health strategies and vaccine efficacy monitoring.

Scientific Research Community

The hearing identifies priorities for federal research funding and focus areas for viral surveillance.

What changed

Last recorded activity January 1, 2022.

What's next

Next step not available in the current record.

Summary

The House held a virtual hearing on May 12, 2021, to discuss the evolution of COVID-19 variants and the ongoing research required to address them. Experts and lawmakers examined the risks of new variants, including potential vaccine resistance and increased transmissibility.

Key Facts

The hearing took place on May 12, 2021, via Zoom.
The Subcommittee on Investigations and Oversight held the hearing to discuss COVID-19 variants and evolving research needs.
As of May 2021, nearly 60 percent of Americans had received at least one COVID-19 vaccination dose.
The hearing addressed the risk of 'escape variants' that could potentially resist vaccine-induced immunity.
The Subcommittee operated under House Resolution 8, which authorized virtual proceedings.
Witnesses included experts from CAPRISA, Yale (epidemiology), Argonne National Laboratory, and Johns Hopkins Center for Health Security.
The hearing included an appendix containing post-hearing questions answered by Dr. Stephen Streiffer.

Why It Matters

This hearing established the federal legislative record on the scientific challenges posed by COVID-19 mutations, which informs future public health funding and national pandemic response strategies.

Frequently Asked Questions

What was the purpose of this hearing?

The hearing was held to gather expert testimony on how COVID-19 variants evolve and what research is needed to monitor and combat them.

Who participated in the hearing?

The hearing was conducted by the House , featuring testimony from four scientific experts in epidemiology and laboratory research.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

temporal pattern100% confidence

Pandemic-era Virtual Governance

The document highlights the reliance on House Resolution 8 to conduct official federal business via Zoom during the 2021 pandemic period.

House Resolution 8

Connected Entities

personBill Foster“Chairman of the Subcommittee on Investigations and Oversight”Map →

personCaitlin Rivers“Witness, Senior Scholar at Johns Hopkins Center for Health Security”Map →

personEddie Bernice Johnson“Chairwoman of the Committee on Science, Space, and Technology”Map →

personStephen Streiffer“Witness, Deputy Laboratory Director at Argonne National Laboratory”Map →

personJay Obernolte“Ranking Member of the Subcommittee”Map →

personNathan Grubaugh“Witness, Assistant Professor of Epidemiology”Map →

personSalim Abdool Karim“Witness, Director of CAPRISA”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance40
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz5
Current news / social attention level

Publisher tools